Adding psychedelics to mainstream drugs may seem a bit “out there,” but in fact it’s on trend… Synthetic versions of psychedelic substances are easier to manufacture uniformly according to industry standards, but they may not work as well as natural versions. “We believe there’s a big difference between biological and synthetic molecules, especially in how…
…people will be able to obtain sterile syringes and other safer-use supplies, access treatment options and other services, and bring their own drugs to use, with trained staff and naloxone on hand. “This is a watershed milestone in the fight to end overdose deaths in New York,” Melissa Moore, the director of civil systems reform…
For the study, participants either received 10mg of escitalopram daily for seven days followed by 20mg daily for the next seven days, including the day of psilocybin administration, or 14 days of placebo pre-treatment before psilocybin administration. The researchers found that pre-treatment with escitalopram did not alter the pharmacokinetics of psilocin — the active compound that the…
Despite the seriousness of those findings, acetaminophen nonetheless remains one of the most used medications in the world, considered an essential medicine by the World Health Organization, and recommended by the CDC for pain relief at home… the findings are reported in Social Cognitive and Affective Neuroscience. “Acetaminophen seems to make people feel less negative emotion when they…
In order to have physical dependence your body needs to start relying on a substance to function properly. …there does not appear to be any sort of physiological mechanism that would make your body “dependent” on psilocin in such a way that you’d experience physical effects from stopping a regimen. In other words, no, you’re…
This examination of a large international sample of adults highlights the prominence of therapeutic and wellness motivations for microdosing psychedelic drugs and identified lower levels of anxiety and depression among microdosers relative to controls. Comparisons of psilocybin to LSD microdosers indicated no differences on measures of Depression, Anxiety and Stress from the DASS-21 (all values for F (1, 827) < 1.0, p > 0.50). The inclusion of…
…[ie] deuterated psilocybin analog has a duration of effect that is half is long as psilocybin, and a duration onset that is twice as fast. …[research pipeline seeking & developing] drugs with less variability [with goals such as] a faster onset time and better brain penetration that maintain the therapeutic properties of psilocybin and deliver…
…a 35-percent response rate and a 5-percent SAE rate means for every seven patients positively responding to the treatment, one person will experience serious negative outcomes… these serious adverse events included suicidal ideation and suicidal behavior. Five patients (6.3 percent) in the 25-mg group and six patients (8 percent) in the 10-mg group experienced at…
With… propriety technology… stable formulations of both psilocin and psilocybin from magic mushrooms. …drug development efforts are focused exclusively on extracting, purifying, and standardizing natural psychedelic compounds. Original Article (Psychedelic Spotlight):FDA approves first clinical trial using naturally sourced psychedelicsArtwork Fair Use: Perdula
…the variability of compounds in magic mushrooms… environmental variables such as light and the type of growing medium influence the presence and amount of certain compounds… in the mushroom fruiting bodies… …isolated and tested for multiple compounds of interest in the mushroom including the tryptamine alkaloids: baeocystin, norbaeocystin, norpsilocin, aeruginascin, 4-HO-TMT, 4-hydroxytryptamine. The beta-carbolines: harmine, harmane, norharmane, harmol. Original Article (Psychedelic Science…
Recent Comments